🇺🇸 FDA
Pipeline program

Dexlansoprazole 60 MG

IM.AS1.48

Approved small_molecule completed

Quick answer

Dexlansoprazole 60 MG for GERD is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
GERD
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials